PNC Financial Services Group
FPRX

PNC Financial Services Group’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

PNC Financial Services Group’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-185
Closed -$2K – 4213
2019
Q1 		$2K Buy
185
+160
+640% +$1.82K ﹤0.01% 3908
2018
Q4 		$0 Sell
25
-19
-43% -$226 ﹤0.01% 4251
2018
Q3 		$1K Buy
+44
New +$654 ﹤0.01% 4082
2018
Q1 		– Sell
-6
Closed – – 4326
2017
Q4 		$0 Hold
6
– – ﹤0.01% 4295
2017
Q3 		$0 Buy
+6
New +$188 ﹤0.01% 4278
2016
Q3 		– Sell
-141
Closed -$6K – 4404
2016
Q2 		$6K Buy
141
+32
+29% +$1.39K ﹤0.01% 3780
2016
Q1 		$4K Sell
109
-18,596
-99% -$639K ﹤0.01% 3969
2015
Q4 		$776K Buy
18,705
+105
+0.6% +$3.52K ﹤0.01% 1316
2015
Q3 		$286K Buy
18,600
+7,600
+69% +$163K ﹤0.01% 1891
2015
Q2 		$274K Hold
11,000
– – ﹤0.01% 2019
2015
Q1 		$252K Hold
11,000
– – ﹤0.01% 2073
2014
Q4 		$298K Sell
11,000
-120
-1% -$2.07K ﹤0.01% 1841
2014
Q3 		$131K Hold
11,120
– – ﹤0.01% 2241
2014
Q2 		$174K Buy
+11,120
New +$159K ﹤0.01% 2000

Other funds holding FPRX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PNC Financial Services Group's FPRX Position: Q2 2019 in Review

PNC Financial Services Group sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2019, closing a stake of 185 shares — an estimated $2K sold.

PNC Financial Services Group first reported a position in FPRX in Q2 2014 and held it in 14 quarters. The position peaked at $776K in Q4 2015. 114 funds tracked by Wall St. Rank hold FPRX as of Q2 2019.

  • PNC Financial Services Group reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
  • PNC Financial Services Group sold 185 Five Prime Therapeutics, Inc. shares in Q2 2019, an estimated $2K.
  • PNC Financial Services Group first reported a position in Five Prime Therapeutics, Inc. in Q2 2014 and held it in 14 quarters.
  • PNC Financial Services Group's Five Prime Therapeutics, Inc. position peaked at $776K in Q4 2015.
  • 114 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2019.

Based on PNC Financial Services Group's 13F filing for Q2 2019, filed 9 Aug 2019.